PHARMACY

FDA to review Actos for bladder cancer risk

BY Alaric DeArment

SILVER SPRING, Md. The Food and Drug Administration said Friday it had begun a safety review of Takeda’s Type 2 diabetes treatment Actos (pioglitazone) after receiving five-year data from a 10-year study Takeda Pharmaceuticals North America is conducting on the drug showing that some patients taking it could be at risk for bladder cancer.

 

The results showed no overall association between taking Actos and risk of bladder cancer, but there was an increased risk among those taking the drug for the longest period of time and in those taking it at the highest cumulative dose. The FDA said it had not concluded that the drug increases patients’ bladder cancer risk.

 

 

Actos belongs to the same class as GlaxoSmithKline’s Avandia (rosiglitazone), which has come under fire lately after being linked to heart problems in patients, though the drug remains available in the United States.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Caraco adds new member to board

BY Alaric DeArment

DETROIT Caraco Pharmaceutical Labs has appointed a new member to its board of directors.

 

The generic drug maker announced Wednesday the appointment of former KPMG accountant Eddie Munson to its board of directors.

 

 

Munson, who served in various positions for KPMG, will serve on Caraco’s board of directors for a term ending at the 2011 annual meeting of shareholders.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Novo Nordisk featured in Working Mother’s ‘100 Best Companies’ list

BY Alaric DeArment

PRINCETON, N.J. Working Mother magazine has named drug maker Novo Nordisk one of the best companies in the country for family-friendly benefits, the company said Thursday.

 

The U.S. subsidiary of the Danish drug maker was named a Working Mother 100 Best Company for programs designed to help families balance work-life needs, such as adoption reimbursement, health benefits, paid time off and assistance for families sending their kids to college.

 

 

“It is an honor to be named as a Working Mother 100 Best Company,” said Novo Nordisk VP human resources Jeff Frazier. “This recognition shows our commitment to supporting a diverse and inclusive work environment, where everyone has an opportunity to participate in creating business success and people are valued for their unique skills, experiences and perspectives.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?